How Come Some People Believe in the Paranormal?
Those who favor Bigfoot, UFOs and ghosts share a thinking style
Those who favor Bigfoot, UFOs and ghosts share a thinking style
The famed neurologist–author found uniqueness in every patient and savored the miracle of existence, whether it be found in squirrel monkeys or people
Jimmy Carter talks about his public health efforts to eradicate guinea worm and improve global mental health and women's health. Plus, magazine collector Steven Lomazow brings part of his collection to the Scientific American 170th birthday party ...
The prolific author–neurologist gave the world empathetic insights into disorders of the brain while also inspiring films, plays, an opera and likely many careers in medicine and brain science...
A broader understanding of bacterial social networks might help scientists combat antibiotic resistance
The brain constantly strives to reconcile its own internal picture of the world with the incoming sensory flood from eyes, ears and other sensory inputs— a process that lets us run, walk and move about the world...
The vast majority of U.S. kindergarten-age children are vaccinated against preventable diseases but sizable pockets of unprotected children still exist, posing a public health threat
The new drug, Repatha (evolocumab), is approved for patients with hereditary forms of high cholesterol and those with cardiovascular disease
Never mind the nanny state, when policy makers use behavioral science to influence our decisions, everybody wins
Neurons involved in Parkinson’s disease are especially susceptible to burnout because of their complex branching
While millions of people are comfortable seeking help from a psychologist, psychiatrist, or other counselor, others—maybe you included—would rather pass a kidney stone than make an appointment with a therapist...
Scientists have no shortage of ideas about how to stop tick-borne illnesses. What is holding them back?
Synthetic marijuana is cheap, widespread, hard to track and highly toxic
A new theory about long-lasting Lyme disease symptoms suggests treatment options
MERS inoculation triggers response in monkeys and camels, raising hopes for future human use
The controversial drug will be headed to the market despite risks of fainting and low blood pressure
Focusing on irrational fears will not help chemistry’s public image
The speedy method makes potent painkilling opioids, but it still must be fine-tuned to make it commercially viable
Researchers isolated a bacterial enzyme that could break down nicotine before smokers get the buzz that keeps them coming back for more. Christopher Intagliata reports
Molecule’s light signals a contaminant in heparin, medicine used by millions of patients
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account